The 2005/06 competition had its final in December 2006, the press release announcing the winner can be found at http://www.rcuk.ac.uk/news/2006/20061208bpc.htm and some background information can be viewed here 
.
Finalists
Biosense Technology – Speeding up pharmaceutical and cosmetic testing with new biosensors
Since the Business Plan Competition, Dr David Naseby and the University of Hertfordshire team received significant investment interest from three groups wishing to invest in the start up company. They have just concluded negotiations with one of the groups and have secured start-up funding totalling £600,000. They are now implementing a business plan to take their products to market.
Progress has been rapid in the six months since the final of the RCUK business plan competition, the team have also secured further funding from the pharmaceutical industry (including GlaxoSmithkline), further resources from other partners (including Pall Corporation) and a number of service contracts with the pharmaceutical and cosmetics industry. Further to that, they secured market development funding from EEDA.
Remarkably Biosense Technology is on course to break even in its first year of trading due to take up of their unique services to industry commencing in September 2007.
http://www.biosensetechnology.co.uk/
Dynamic Therapeutics - Medical device for patients with respiratory disorders dependant on oxygen therapy.
Since the competition this team has been dedicated to pursuing the business plan for Dynamic Therapeutics Ltd. The award from the RCUK, together with other prizes from the Royal Academy of Engineering and Tanaka Business School, have allowed them to accelerate product development to CE Mark their Saturation Driven Oxygen Therapy (SDOT) device.
Team member, Mario Lobbi, said: "Probably the most rewarding experience has been the response directly from patients on oxygen therapy, several of whom contacted the company directly wanting to know when they would be able to buy a SDOT device for themselves."
They are currently seeking out potential partners and investors to bring this opportunity to the next stage of development. Some of their most recent developments are also available on their website.
Eykona Technologies – From healthcare to video gaming – unlocking the potential of 3D imaging
Eykona are now fully spun out of Oxford University and are in the process of preparing their final business-plan draft. They are entering the commercial stage of talks with several video games companies and are also making inroads to the medical community. Seed investment and management support is being provided by H2O Venture Partners.
http://www.eykona.com/
Oral Vaccination – aiding the global fight against disease
The Strathclyde University team are currently talking to a Canadian company who are interested in a collaborative research project and a licensing deal to develop a novel oral influenza vaccine. Dr Valerie Ferro, leading the team, said: "The data obtained in constructing the business plan was useful in putting a proposal to the company. We are also about to file a new patent thanks to the mentoring received whilst working on the business plan."
TotallyTextures – Computer animated surface textures
The Totally Textures team are filling a gap in the market with their low-cost patented methods for capturing, managing, visualising and searching digital databases of surface textures. They are well underway with a portfolio of integrated products and have just signed their first contract. They will be officially starting business by the end of April.
http://www.totallytextures.com/
UltraSOC Technologies – combating the software bugs that affect the reliability of consumer products
Technical development continues for the UltraSOC team and they are currently in talks with several major embedded systems manufacturers. They will be looking to raise further funding and capital later this year.
http://www.ultrasoc.com/
Warwick Warp – Unique software-based fingerprint identification system
Since winning the RCUK Business Plan Competition, Warwick Warp's technical team has made substantial progress on product development. The internal performance testing and benchmarking is completed and shows clear advantage of Warwick Warp’s approach over existing technology. The company is working closely with market leaders on product evaluation. It is also in the process of securing its second round funding.